Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

517 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Suboptimal Uptake, Retention, and Adherence of Daily Oral Prexposure Prophylaxis Among People With Opioid Use Disorder Receiving Hepatitis C Virus Treatment.
Brokus C, Kattakuzhy S, Gayle B, Narayanan S, Davis A, Cover A, Eyasu R, Ebah E, Ogbumbadiugha-Weekes O, Hoffmann J, Silk R, Stevens J, Mount J, Gannon C, Nussdorf L, Mathur P, Bijole P, Jones M, Kier R, Sternberg D, Greenblatt A, Weintraub E, Masur H, Kottilil S, Rosenthal E. Brokus C, et al. Among authors: masur h. Open Forum Infect Dis. 2021 Dec 29;9(3):ofab658. doi: 10.1093/ofid/ofab658. eCollection 2022 Mar. Open Forum Infect Dis. 2021. PMID: 35187191 Free PMC article.
Concurrent Initiation of Hepatitis C and Opioid Use Disorder Treatment in People Who Inject Drugs.
Rosenthal ES, Silk R, Mathur P, Gross C, Eyasu R, Nussdorf L, Hill K, Brokus C, D'Amore A, Sidique N, Bijole P, Jones M, Kier R, McCullough D, Sternberg D, Stafford K, Sun J, Masur H, Kottilil S, Kattakuzhy S. Rosenthal ES, et al. Among authors: masur h. Clin Infect Dis. 2020 Oct 23;71(7):1715-1722. doi: 10.1093/cid/ciaa105. Clin Infect Dis. 2020. PMID: 32009165 Free PMC article.
PrEP Indications and PrEP Knowledge, Access, and Interest Among Individuals With HCV.
Hill KC, Kattakuzhy SM, Silk R, Eyasu R, Ogbumbadiugha O, Ebah E, Cover AA, Davis A, Gayle B, Sternberg D, Bijole P, Sun J, Masur H, Kottilil S, Solomon D, Rosenthal ES. Hill KC, et al. Among authors: masur h. Open Forum Infect Dis. 2022 Sep 14;9(10):ofac476. doi: 10.1093/ofid/ofac476. eCollection 2022 Oct. Open Forum Infect Dis. 2022. PMID: 36225745 Free PMC article.
Initiation of Low-threshold Buprenorphine in Nontreatment Seeking Patients With Opioid Use Disorder Engaged in Hepatitis C Treatment.
Hill K, Nussdorf L, Mount JD, Silk R, Gross C, Sternberg D, Bijole P, Jones M, Kier R, Mccullough D, Mathur P, Kottilil S, Masur H, Kattakuzhy S, Rosenthal ES. Hill K, et al. Among authors: masur h. J Addict Med. 2022 Jan-Feb 01;16(1):10-17. doi: 10.1097/ADM.0000000000000807. J Addict Med. 2022. PMID: 33560694 Free PMC article.
Expansion of Treatment for Hepatitis C Virus Infection.
Emmanuel B, Masur H, Kottilil S, Kattakuzhy S. Emmanuel B, et al. Among authors: masur h. Ann Intern Med. 2018 Mar 20;168(6):457-459. doi: 10.7326/L17-0698. Ann Intern Med. 2018. PMID: 29554678 No abstract available.
A pilot study of safety and efficacy of HCV retreatment with sofosbuvir/velpatasvir/voxilaprevir in patients with or without HIV (RESOLVE STUDY).
Wilson E, Covert E, Hoffmann J, Comstock E, Emmanuel B, Tang L, Husson J, Chua J, Price A, Mathur P, Rosenthal E, Kattakuzhy S, Masur H, Kottilil S. Wilson E, et al. Among authors: masur h. J Hepatol. 2019 Sep;71(3):498-504. doi: 10.1016/j.jhep.2019.05.021. Epub 2019 Jun 5. J Hepatol. 2019. PMID: 31173815 Free PMC article. Clinical Trial.
Moderate Sustained Virologic Response Rates With 6-Week Combination Directly Acting Anti-Hepatitis C Virus Therapy in Patients With Advanced Liver Disease.
Kattakuzhy S, Wilson E, Sidharthan S, Sims Z, McLaughlin M, Price A, Silk R, Gross C, Akoth E, McManus M, Emmanuel B, Shrivastava S, Tang L, Nelson A, Teferi G, Chavez J, Lam B, Mo H, Osinusi A, Polis MA, Masur H, Kohli A, Kottilil S. Kattakuzhy S, et al. Among authors: masur h. Clin Infect Dis. 2016 Feb 15;62(4):440-447. doi: 10.1093/cid/civ897. Epub 2015 Oct 26. Clin Infect Dis. 2016. PMID: 26503379 Free PMC article. Clinical Trial.
Successful Retreatment of Chronic HCV Genotype-1 Infection With Ledipasvir and Sofosbuvir After Initial Short Course Therapy With Direct-Acting Antiviral Regimens.
Wilson EM, Kattakuzhy S, Sidharthan S, Sims Z, Tang L, McLaughlin M, Price A, Nelson A, Silk R, Gross C, Akoth E, Mo H, Subramanian GM, Pang PS, McHutchison JG, Osinusi A, Masur H, Kohli A, Kottilil S. Wilson EM, et al. Among authors: masur h. Clin Infect Dis. 2016 Feb 1;62(3):280-288. doi: 10.1093/cid/civ874. Epub 2015 Oct 31. Clin Infect Dis. 2016. PMID: 26521268 Free PMC article. Clinical Trial.
517 results